Given that fetal adrenal development and maturation occur during late gestation in rats, the aim of this study was to evaluate the expression of proteins and enzymes involved in steroidogenesis and catecholamine synthesis in adrenal glands from IUGR fetuses. A gene microarray was performed to investigate for alteration in the pathways participating in hormone production. Results show that increased aldosterone serum concentrations in IUGR fetuses were associated with higher mRNA adrenal levels of angiotensin II receptor type 1 (AT1R) and cytochrome P450 aldosterone synthase in response to decreased serum sodium content. Conversely, reduced serum corticosterone concentrations in these fetuses appear to result from alterations in gene expression involved in cholesterol metabolism, such as the augmented apolipoprotein E levels, and in steroidogenesis, like the decreased levels of cytochrome P45011␤-hydroxylase. Furthermore, increased AT2R expression and the presence of hypoxia and oxidative stress may, in turn, explain the higher adrenal mRNA levels of enzymes involved in catecholamine synthesis. Despite this increase, catecholamine adrenal content was reduced in males and was similar in females compared with sex-matched controls, suggesting higher catecholamine secretion. This could be associated with the induction of genes involved in inflammation-related, acute-phase response in IUGR fetuses. All of these alterations could have long-lasting health effects and may, hence, be implicated in the pathogenesis of increased blood pressure and cardiac hypertrophy observed in IUGR adult animals from this model. fetal programming; developmental plasticity; steroidogenesis; catecholamine ASSOCIATION BETWEEN LOW BIRTH weight and the increased risk of cardiovascular and metabolic diseases in adult life has been confirmed by many epidemiological and animal studies (2, 27). These links could be explained by the processes of normal developmental plasticity that can be affected in response to environmental factors during early life. Indeed, fetal adaptations as a response to impaired intrauterine environment lead to fine physiological settings (alterations in tissue anatomy or microanatomy, cellular activity, and gene expression), which, in turn, can be maladaptative to adult life (3, 13). For example, prenatal hypoxia in rats has been reported to delay the maturation of the adrenal medulla, evidenced by the lower percentage of chromaffin cells expressing tyrosine hydroxylase (TH) and phenylethanolamine N-methyl transferase (PNMT) until postnatal day 7, compared with normoxic offspring (23). Interestingly, the decreased TH activity at 10 wk of age suggests that this impaired adrenal function persists until adulthood (23). In sheep, experimental restriction of placental function (removing endometrial caruncles prior to mating) results in growth-restricted fetuses that present an increase in adrenal gland weight associated with higher plasma cortisol (32), likely due to enhanced expression of cholesterol side-chain cleavage cytochrome P450 mRNA (34). All of these observations suggest that environmental signals in utero can induce permanent phenotypic changes in the adrenal gland.
Given that fetal adrenal development and maturation occur during late gestation in rats, the aim of this study was to evaluate the expression of proteins and enzymes involved in steroidogenesis and catecholamine synthesis in adrenal glands from IUGR fetuses. A gene microarray was performed to investigate for alteration in the pathways participating in hormone production. Results show that increased aldosterone serum concentrations in IUGR fetuses were associated with higher mRNA adrenal levels of angiotensin II receptor type 1 (AT1R) and cytochrome P450 aldosterone synthase in response to decreased serum sodium content. Conversely, reduced serum corticosterone concentrations in these fetuses appear to result from alterations in gene expression involved in cholesterol metabolism, such as the augmented apolipoprotein E levels, and in steroidogenesis, like the decreased levels of cytochrome P45011␤-hydroxylase. Furthermore, increased AT2R expression and the presence of hypoxia and oxidative stress may, in turn, explain the higher adrenal mRNA levels of enzymes involved in catecholamine synthesis. Despite this increase, catecholamine adrenal content was reduced in males and was similar in females compared with sex-matched controls, suggesting higher catecholamine secretion. This could be associated with the induction of genes involved in inflammation-related, acute-phase response in IUGR fetuses. All of these alterations could have long-lasting health effects and may, hence, be implicated in the pathogenesis of increased blood pressure and cardiac hypertrophy observed in IUGR adult animals from this model. fetal programming; developmental plasticity; steroidogenesis; catecholamine ASSOCIATION BETWEEN LOW BIRTH weight and the increased risk of cardiovascular and metabolic diseases in adult life has been confirmed by many epidemiological and animal studies (2, 27) . These links could be explained by the processes of normal developmental plasticity that can be affected in response to environmental factors during early life. Indeed, fetal adaptations as a response to impaired intrauterine environment lead to fine physiological settings (alterations in tissue anatomy or microanatomy, cellular activity, and gene expression), which, in turn, can be maladaptative to adult life (3, 13) . For example, prenatal hypoxia in rats has been reported to delay the maturation of the adrenal medulla, evidenced by the lower percentage of chromaffin cells expressing tyrosine hydroxylase (TH) and phenylethanolamine N-methyl transferase (PNMT) until postnatal day 7, compared with normoxic offspring (23) . Interestingly, the decreased TH activity at 10 wk of age suggests that this impaired adrenal function persists until adulthood (23) . In sheep, experimental restriction of placental function (removing endometrial caruncles prior to mating) results in growth-restricted fetuses that present an increase in adrenal gland weight associated with higher plasma cortisol (32) , likely due to enhanced expression of cholesterol side-chain cleavage cytochrome P450 mRNA (34) . All of these observations suggest that environmental signals in utero can induce permanent phenotypic changes in the adrenal gland.
The rat fetal adrenal glands develop at approximately embryonic day 13 (E13) and are composed of two tissues with distinct embryological origins, namely the cortex and the medulla (31, 50) . Cortex zona glomerulosa and zona fasciculata/reticularis cell phenotypes, evidenced, respectively, by the expression of P450 cytochrome aldosterone synthase (P450aldo) and 11␤-hydroxylase (P45011␤), appear on E16 (49) . The simultaneous detection of mRNA for receptors of angiotensin II (ANG II) subtypes 1 and 2 (AT 1 R and AT 2 R) (40, 41) and of the adenocorticotropic hormone melanocortin type 2 receptor (10), both of which are two main regulators of steroidogenesis, as well as the detection of adrenal aldosterone and corticosterone content, suggest a functional activity of the rat fetal gland (49) . The adult-like zonation of the adrenal cortex appears near time of birth (28) . Expression of TH, the rate-limiting step in catecholamine synthesis, is detectable in medullary cell precursors (46) , although the capacity to synthesize epinephrine is acquired by E16-E18 with the appearance of PNMT (38) . Thus, the conversion of medullary cell precursors into chromaffin cells occurs before birth (50) . However, some TH positive cells are still present within the adrenal cortex until the first days of postnatal life, indicating a late maturation of the adrenal medulla (28) . Thus, the morphological and functional relative immaturity of rat adrenal glands during late gestation may render these glands more sensitive to adverse intrauterine environmental conditions.
In our laboratory, an animal model of fetal unfavorable environment was developed by administering a low-sodium diet to rats during the last week of gestation (35) . This diet was used as a tool to prevent plasma volume expansion, which normally occurs during gestation (7) . The ensuing decrease in uterine artery diameter and placental weight, compared with normal pregnant rats, indicates an impaired placental perfusion that could be implicated in observed intrauterine growth restriction (IUGR) (35, 43) . As young adults, these IUGR offspring were shown to manifest a modest increase in systolic blood pressure (9 mmHg), alteration in the renin-angiotensin-aldosterone system, renal dysfunction evidenced by reduced glomerular filtration (5) , and hypertrophic cardiac remodeling (4), all of which represent risk factors for the onset of cardiovascular diseases. These results, hence, support the link between adverse fetal environment and the development of adult diseases, confirming this model as a good paradigm for the study of fetal programming.
In view of the time frame for the development and maturation of adrenal glands, and considering that, in the model used, the adverse environment (maternal low-sodium intake) occurs from E15 until term, we hypothesized that the adrenal glands of IUGR pups adapt to this particular condition and may thus be responsible, in part, for the higher risks of developing cardiovascular diseases. The first aim of the present report was therefore to determine, in the fetal adrenal glands, the expression of proteins and enzymes involved in steroidogenesis and catecholamine synthesis. Results obtained clearly revealed alterations in pathways leading to adrenal hormone synthesis in IUGR fetuses. These observations led to the second aim, which was to investigate the causes and/or consequences of these adrenal changes by performing a microarray analysis to compare gene expression patterns in adrenal glands from both IUGR fetuses and their control counterparts.
MATERIALS AND METHODS
Animals, experimental design, and tissue preparation. This study was approved by our Institutional Animal Care Committee, which is accredited by the Canadian Council on Animal Care. Female SpragueDawley rats (Charles River Canada, St-Constant, QC, Canada) weighing 225-250 g were mated with a known fertile male. Day 1 of pregnancy was determined by the presence of spermatozoa in morning vaginal smears. All animals were housed under controlled lighting (6:00 AM-6:00 PM) and temperature (21 Ϯ 3°C). The dams were randomly assigned to one of two diets for the last 7 days of gestation (term ϭ day 23). One group was fed a normal diet containing 0.2% sodium and 0.40% potassium (normal diet 5755; PMI Feed, Ren's Feed and Supplies, Oakville, ON, Canada) and tap water. Their fetuses represent the control group. The second group received a low-sodium diet containing 0.03% sodium and 0.85% potassium (low-sodium diet 5881; PMI Feed) and demineralized water. The composition of the control and experimental diets is similar in protein (19%), carbohydrate (60.6%), and fat (10%) content. As previously shown (35) , fetuses from this group suffered from IUGR (n ϭ 29 litters) vs. control (n ϭ 32 litters) (male weight: 4.7 Ϯ 0.5 g vs. 5.2 Ϯ 0.5 g, Student's t-test, P Ͻ 0.001; female weight: 4.4 Ϯ 0.5 g vs. 4.9 Ϯ 0.4 g, Student's t-test, P Ͻ 0.001). On day 22 of gestation, dams and fetuses were decapitated (8:00 AM-9:00 AM). Fetuses were separated by sex. Trunk blood was collected for hormone and electrolyte analyses. Adrenal glands were quickly removed, pooled by sex and litter, and snap-frozen in liquid nitrogen (n ϭ 1 represents sex-pooled adrenal glands from 1 litter for each group).
Sample collection and blood analysis. Trunk blood from male and female fetuses was collected in a plain Vacutainer tube (Becton Dickinson, Franklin Lakes, NJ) and centrifuged at 1,550 g for 20 min at 4°C (n ϭ 1 represents sex-pooled blood from 1 litter for each group). Serum samples were then stored at Ϫ80°C for subsequent measurement of sodium and potassium concentrations with specific electrodes as well as aldosterone (Intermedico, Montréal, QC, Canada) and corticosterone (Medicorp, Montréal, QC, Canada) content via a commercial radioimmunoassay kit.
Determination of adrenal catecholamine content. The adrenal glands (20 mg/ml) were homogenized in 2% (vol/vol) formic acid in HPLC grade water and subsequently disrupted by ultrasonication. Fifty microliters of the homogenate were suspended in 940 l of methanol (HPLC grade; Baker, Philipsburg, NJ), containing 10 l of isoproterenol (2 g/ml) as an internal standard, and centrifuged (8,800 g, 15 min). Supernatant was collected, and separations of catecholamines were performed on a Surveyor LC system coupled to a Quantum Ultra AM triple quadrupole mass spectrometer (both from Thermo Fisher, San Jose, CA) by the Regional Centre of Mass Spectrometry (Université de Montréal) by a modified method of Gu et al. (14) . In brief, a 20-l aliquot was injected into a reverse-phase column (5 m, 150 ϫ 3.0 mm Luna CN; Phenomenex, Torrance, CA). Elution was performed with a mobile phase consisting of 60% (vol/vol) acetonitrile and 40% (vol/vol) water containing 0.1% (vol/ vol) formic acid at a flow rate of 0.35 ml/min. Norepinephrine and epinephrine were quantified by positive ionization electrospray tandem mass spectrometry. The transitions used for the quantitation of compounds in the mixture under the SRM mode are 170.1¡152.1 for norepinephrine, 184.1¡107.1 for epinephrine, and 212.1¡194.1 for the isoproterenol. Liquid chromatography/mass spectrometry data were acquired and processed using Xcalibur 2.0 software. Calibration curves were generated simultaneously for epinephrine and norepinephrine by plotting the analyte to isoproterenol area ratios vs. the corresponding standard concentrations. A linear response with a correlation coefficient (r 2 ) of 0.9993 was obtained for norepinephrine for concentrations ranging from 1 to 500 ng/ml. For epinephrine, a linear response with a correlation coefficient (r 2 ) of 0.9986 was obtained for concentrations ranging from 1 to 400 ng/ml. The limits of quantitation (defined as S/N ϭ 10) were 1 ng/ml for both analytes. Serum catecholamine levels could not be measured due to the low concentration and to the availability of serum.
RNA isolation, RT-PCR, and gene expression microarray. Total RNA from adrenal glands was extracted by Trizol reagent (Invitrogen Canada, Burlington, ON, Canada). Final RNA pellets were dissolved in an appropriate volume of diethylpyrocarbonate water and stored at Ϫ80°C. RNA concentration was established by absorbance measurement at a wavelength of 260 nm, with sample integrity ascertained by the 260/280 nm ratio. Quality was verified by ethidium bromide fluorescence. For RT-PCR, adrenal glands from six litters/group were used. For the microarray assay, adrenal glands from two control and two IUGR litters were pooled.
PCR primers specific for genes related to 1) steroidogenic activity in the adrenal cortex [AT1R and AT2R, P450aldo, P45011␤, and steroidogenic acute regulatory protein (StAR)];2) catecholamine synthesis in the adrenal medulla [dopamine ␤-hydroxylase (D␤H), PNMT, TH]; and 3) VEGF as a marker for hypoxia, as well as GAPDH as an internal control were designed with PRIMER 3 http:// frodo.wi.mit.edu/primer3/ based on sequence data from the National Center for Biotechnology Information (Table 1) . Single-stranded cDNA was created by RT (SuperScript II RNase H-Reverse Transcriptase, Invitrogen) and PCR (Taq DNA Polymerase, Invitrogen) performed according to the procedure detailed by the manufacturer. The annealing step was carried out for 1 min at temperatures established for each gene in fetal adrenal glands ( Table 1 ). The extension step was performed at 72°C for 1 min. PCR results were collected during the exponential phase. The number of cycles needed for amplification was determined for each gene (Table 1) . To ensure that genomic DNA was not amplified, RT was performed without enzyme, and PCR was conducted as previously described. PCR products were assessed by electrophoresis on 1% agarose gels and visualized by ethidium bromide fluorescence. Amplification products were quantified by Alpha Imager software (Alpha Innotech). The procedure was conducted on triplicate samples, and results are reported on GAPDH as internal control.
Gene expression microarray was performed as previously described (4). In brief, fragmented cRNA (15 mg) was hybridized to the U34A GeneChip (Affymetrix, Santa Clara, CA), and the microarray was processed in an Affymetrix GeneChip Fluidic Station 400. The results were analyzed as described elsewhere (37) . Genes were considered to be present at 95% confidence (P Ͻ 0.05) for their expres-sion and differentially expressed when a minimum twofold (arbitrary cut-off) difference between IUGR and control values was evident.
RNA isolation and quantitative RT-PCR analysis. Total cellular RNA from adrenal glands was extracted using RNeasy Plus Mini Kit (Qiagen, Mississauga, ON, Canada) according to the manufacturer's instructions. Single-stranded cDNA was generated by RT (QuantiTect Reverse Transcription Kit; Qiagen) using 0.75 g of total RNA according to the procedure detailed by the manufacturer. PCR product was amplified using certified QuantiTect Primers Assays (Qiagen) listed in Table 1 . PCR was done with ABI PRISM 7000 Sequence Detection System (Applied Biosystems, Foster City, CA) using the QuantiTect SYBR Green PCR Kit (Qiagen) according to manufacturer's instructions. All reactions were composed of 2.5 l cDNA in 12.5 l QuantiTect SYBR Green Master Mix (Qiagen), 2.5 l QuantiTect Primer Assay (Qiagen), 7.0 l RNase free water, and 0.5 l (0.5 unit) uracil-DNA-glycosylase (Invitrogen Canada, Burlington, ON, Canada). The procedure was carried out on triplicates from individual litters (n ϭ 6/group). Results are expressed relatively to 18S (internal control gene).
VEGF, P45011␤, Bax, and Bcl-2 protein expression.
Frozen adrenal glands (n ϭ 10/group) were homogenized in a commercial lysis buffer (1:4 wt/vol) and centrifuged at 12,000 g for 15 min at 4°C. Supernatants were collected and used to determine VEGF protein concentrations with an ELISA commercial kit (RayBio Rat VEGF Elisa kit; RayBiotech, Norcross, GA) according to the procedure detailed by the manufacturer.
Frozen adrenal glands (n ϭ 6/group) were homogenized in lysis buffer (1:4 wt/vol) containing 50 mM Tris·HCl buffer (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1% NP-40, 0.25% sodium deoxycholate, and 1ϫ complete EDTA-free protease inhibitor cocktail tablet (Roche, Indianapolis, IN) and centrifuged at 12,000 g for 30 min at 4°C. Supernatants were collected and subsequently resuspended in Laemmli buffer. Twenty-five micrograms were separated by SDS-PAGE (P45011␤: 10%, Bax and Bcl-2: 15%) and then transferred electrophoretically onto nitrocellulose membranes (Fisher Scientific, Nepean, Ontario, Canada). Nonspecific sites on the membranes were blocked for 1 h at room temperature in 5% skim milk (P45011␤, Bax) or 5% BSA (Bcl-2) PBS (1.4 M NaCl, 2.7 mM KCl, 100 mM 
RESULTS

Effects of maternal low-sodium diet on fetal serum electrolytes and corticoids.
Fetal adverse environment by administration of low-sodium diet to pregnant rats induced, in term fetuses, a decrease in serum sodium levels (P Ͻ 0.001, twofactor ANOVA; controls vs. sex-matched IUGR: males, 136 Ϯ 2 vs. 130 Ϯ 4 mmol/l, P Ͻ 0.001; females, 140 Ϯ 2 vs. 132 Ϯ 4 mmol/l, P Ͻ 0.001, Newman-Keuls test) reflecting reduced natremy in dams (35) . Sodium levels also presented a significant sex difference (P Ͻ 0.01, two-factor ANOVA) with higher concentrations in control females than in control males (P Ͻ 0.01, Newman-Keuls test). Serum potassium levels were similar in all studied groups. Serum aldosterone concentrations (pmol/l) were markedly elevated in IUGR fetuses (P Ͻ 0.001, two-factor ANOVA; controls vs. sex-matched IUGR: males, 1.0 Ϯ 0.3 vs. 7.1 Ϯ 1.2, P Ͻ 0.001 and females, 0.9 Ϯ 0.2 vs. 7.3 Ϯ 1.5, P Ͻ 0.001, Newman-Keuls test), whereas serum corticosterone concentrations (nmol/ml) were decreased in IUGR fetuses (P Ͻ 0.001, two-factor ANOVA; controls vs. sex-matched IUGR: males, 1.06 Ϯ 0.04 vs. 0.92 Ϯ 0.04, P Ͻ 0.05 and females, 1.10 Ϯ 0.06 vs. 0.80 Ϯ 0.03, P Ͻ 0.001, Newman-Keuls test). There were no differences in these hormone levels between control males and females. These results indicate that a low-sodium diet given to pregnant rats modifies fetal adrenal steroidogenesis in both sexes by favoring mineralocorticoid over glucocorticoid production.
Effects of maternal low-sodium diet on fetal adrenal gland steroidogenic pathway. To better characterize the pathway leading to changes in corticoid adrenal gland production in IUGR fetuses, expression of the most important genes involved in their synthesis was measured. AT 1 R mRNA expression (Fig. 1A) , by which ANG II regulates aldosterone synthesis, was increased in adrenal glands from IUGR fetuses compared with controls (P Ͻ 0.001, two-factor ANOVA). This difference was significant for females only (P Ͻ 0.05, Newman-Keuls test). In addition, AT 1 R mRNA levels were significantly enhanced in females compared with males (P Ͻ 0.01, two-factor ANOVA). Adrenal glands from IUGR fetuses had higher mRNA levels of the key enzyme in aldosterone synthesis, P450aldo (P Ͻ 0.001, twofactor ANOVA; Fig. 1B ) in males as in females (P Ͻ 0.001, Newman-Keuls test). Fig. 1 . mRNA expression of receptor of ANG II subtype 1 (AT1R; A) and P450 cytochrome aldosterone synthase (P450aldo; B) in adrenal glands from day 22 control (white bars) and intrauterine growth restriction (IUGR; gray bars) male and female fetuses. Representative gel: each sample was performed in triplicate, 6 samples/group, and a negative control between IUGR and control samples. Fifty-well combs were used. For purposes of conciseness, 6 consecutive wells and representative of all the samples are illustrated herein, along with dividing lines for each 6-well series representing replicates for each sample. Results are expressed as means Ϯ SE from sex-pooled adrenal glands from 6 litters/group. Two-factor ANOVA reveals a significant effect of maternal treatment for AT1R and P450aldo mRNA levels (P Ͻ 0.001) as well as a significant effect of sex for AT1R mRNA expression (P Ͻ 0.01). *P Ͻ 0.05 and ***P Ͻ 0.001, mean values significantly different from control sex-matched animals (Newman-Keuls test).
On the other hand, mRNA levels of StAR, which mediates the transfer of cholesterol from the outer to the inner membrane of the mitochondria, were decreased in adrenal glands from IUGR fetuses compared with controls (P Ͻ 0.05, two-factor ANOVA; Fig. 2A ). Since P45011␤ mRNA levels displayed a similar pattern without reaching statistical significance (Fig. 2B) , protein expression of this main enzyme involved in corticosterone synthesis was also determined. P45011␤ immunoreactive band intensity and protein expression (when converted to arbitrary units by densitometric analyses) were reduced in adrenal glands from IUGR fetuses compared with controls (P Ͻ 0.01, two-factor ANOVA), although statistical significance was only reached in males (P Ͻ 0.05, Newman-Keuls test; Fig. 2C ). Also, there was a sex difference for P45011␤ mRNA and protein expression (respectively, P Ͻ 0.05 and P Ͻ 0.01, two-factor ANOVA) with augmented levels in females. The above results suggest that in adrenal glands of fetuses from low-sodium dams, higher AT 1 R and P450aldo P45011␤; B) , and protein expression of P45011␤ (C) in adrenal glands from day 22 control (white bars) and IUGR (gray bars) male and female fetuses. Representative gels for A and B: each sample was performed in triplicate, 6 samples/group, and a negative control between IUGR and control samples. Fifty-well combs were used. For purposes of conciseness, 6 consecutive wells and representative of all the samples are illustrated herein, along with dividing lines for each 6-well series representing replicates for each sample. Representative immunoblots and data from densitometric analyses expressed in arbitrary units to ␤-actin are shown in C. Results are expressed as means Ϯ SE from sex-pooled adrenal glands from 6 litters/group. Two-factor ANOVA reveals a significant effect of maternal treatment for StAR mRNA levels (P Ͻ 0.05) and P45011␤ protein expression (P Ͻ 0.01) as well as a significant effect of sex for P45011␤ mRNA (P Ͻ 0.05) and mRNA levels (P Ͻ 0.01). *Mean values significantly different from control sex-matched animals (Newman-Keuls test, P Ͻ 0.05).
mRNA levels are related with aldosterone secretion by the zona glomerulosa, whereas StAR mRNA, as well as P45011␤ levels, decrease in parallel with corticosterone serum levels produced by the zona fasciculata/reticularis.
Effects of maternal low-sodium diet on fetal adrenal gland catecholaminergic pathway. To estimate the potential of the adrenal gland to produce catecholamines, experiments were conducted to measure mRNA expression of the enzymes involved in their synthesis (TH, D␤H, PNMT). As shown in Fig. 3, A-C, mRNA levels of all enzymes were increased in adrenal glands from IUGR fetuses compared with controls (P Ͻ 0.01 for D␤H and P Ͻ 0.001 for TH and PNMT, two-factor ANOVA). In males, this difference reached statistical significance for TH (P Ͻ 0.05, Newman-Keuls test, Fig. 3A ) and PNMT (P Ͻ 0.001, Newman-Keuls test, Fig. 3C ), whereas in females, expression of all enzymes was increased (P Ͻ 0.05 for D␤H and P Ͻ 0.01 for TH and PNMT, Newman-Keuls test). In addition, there was a sex difference in PNMT mRNA levels Fig. 3 . mRNA expression of tyrosine hydroxylase (TH; A), dopamine ␤-hydroxylase (D␤H; B), phenylethanolamine N-methyl transferase (PNMT; C), and AT2R (D) in adrenal glands from day 22 control (white bars) and IUGR (gray bars) male and female fetuses. Representative gel: each sample was performed in triplicate, 6 samples/group, and a negative control between IUGR and control samples. Fifty-well combs were used. For purposes of conciseness, 6 consecutive wells and representative of all the samples are illustrated herein, along with dividing lines for each 6-well series representing replicates for each sample. Results are expressed as means Ϯ SE from sex-pooled adrenal glands from 6 litters/group. Two-factor ANOVA reveals a significant effect of maternal treatment for AT2R mRNA (P Ͻ 0.05), D␤H protein (P Ͻ 0.01), and TH and PNMT mRNA (P Ͻ 0.001), as well as a significant effect of sex for PNMT (P Ͻ 0.001). *P Ͻ 0.05, **P Ͻ 0.01, and ***P Ͻ 0.001, mean values significantly different from control sex-matched animals (Newman-Keuls test). † †Mean value significantly different from that of control male fetuses (Newman-Keuls test, P Ͻ 0.01).
(P Ͻ 0.001, two-factor ANOVA) with an increase in control females compared with control males (P Ͻ 0.01, NewmanKeuls test). mRNA expression of AT 2 R was also measured, since presence of this receptor in the medulla has been linked to catecholamine synthesis and release (8) . As shown in Fig. 3D , AT 2 R mRNA expression was increased in IUGR fetuses (P Ͻ 0.05, two-factor ANOVA).
The norepinephrine adrenal content (nmol/mg of tissue) was measured (controls vs. sex-matched IUGR: males, 0.08 Ϯ 0.02 vs. 0.06 Ϯ 0.01; females, 0.05 Ϯ 0.01 vs. 0.06 Ϯ 0.01). It was decreased in female compared with male fetuses (P Ͻ 0.05, two-factor ANOVA). An interaction between maternal treatment and sex was observed (P Ͻ 0.05, two-factor ANOVA). Student's t-tests revealed significant reductions of norepinephrine adrenal content in IUGR males compared with their controls (P Ͻ 0.05) and increased levels in control male compared with control female fetuses (P Ͻ 0.01). The epinephrine adrenal content (nmol/mg of tissue) was reduced by maternal treatment (P Ͻ 0.001, two-factor ANOVA; controls vs. sex-matched IUGR: males, 0.22 Ϯ 0.06 vs. 0.13 Ϯ 0.02; females, 0.18 Ϯ 0.04 vs. 0.17 Ϯ 0.04). Presence of an interaction between maternal treatment and sex (P Ͻ 0.01, twofactor ANOVA) was found. Decreased epinephrine content was significant only in IUGR males (P Ͻ 0.05, Student's t-test).
Taken together, these results suggest that a low-sodium diet given to pregnant rats induces an alteration of the catecholaminergic pathway in fetal adrenal glands.
Effects of maternal low-sodium diet on fetal adrenal gland gene expression. To pinpoint the possible mechanisms implicated in altered adrenal steroidogenesis and in the increased catecholaminergic pathway observed in IUGR fetuses, gene expression microarray methodology was performed on female fetal adrenal glands. At the end of rat gestation, levels of 17␤-estradiol are similar in male and female fetuses (15) , whereas testosterone levels are significantly higher in males than in females (6). Because we wanted to minimize the influence of testosterone, adrenal glands from female fetuses were chosen. Moreover, we have already shown that cardiomyocyte remodeling was more clearly detected in adult females than in males (4). After withdrawal of duplicates, there were 56 genes differentially expressed (at least by twofold) in adrenal glands from IUGR female fetuses compared with controls. Our analysis revealed six functional classes ( Table 2) . Five of these gene classes (immunological processes, hypoxia, oxidative stress, lipid metabolism and steroidogenesis, and regulation of cell growth) highlighted biological processes that could link an adverse intrauterine environment to changes observed in the fetal adrenal gland. Immunological processes were overrepresented with more than 35% of the differentially expressed probe sets, including many acute-phase proteins, such as haptoglobulin (Hp), fibrinogen (Fg), ␣1 microglobulin/ bikunin (Ambp), complement component 3, albumin (Alb), and ␣-fetoprotein. Expression of four genes known to be direct hypoxia target genes [insulin-like growth factor binding protein 1 (Igfbp1); transferrin (Trf), signal recognition particle receptor, B subunit; aldolase A; ceruloplasmin] was higher in adrenal glands from IUGR female fetuses compared with controls. The increased expression of antioxidants, such as thioredoxin interacting protein and Alb is relevant with the presence of oxidative stress. Moreover, certain genes were assigned to more than one of these three functional classes, illustrating an interrelation between these mechanisms. Specific genes related to lipid metabolism and steroidogenesis underscored the alterations observed in adrenal glands of IUGR fetuses. Expression of genes related to cholesterol metabolism were either in favor of cholesterol utilization, such as the decrease in acetyl-coenzyme A acetyltransferase 2 expression, or in favor of cholesterol storage, such as the increased expression of apolipoprotein E (ApoE). As previously observed ( Fig. 2A) , there was a decreased StAR expression. Overexpression of genes related to regulation of cell growth was also observed, such as Igfbp1, serine (or cysteine), proteinase inhibitor, clade A (␣-1 antiproteinase, antitrypsin), member 1 (Serpina1), and vitronectin. Finally, the other genes differently expressed between IUGR and control fetal adrenal glands were primarily enzymes or were associated with transport.
To validate some of these data, one gene from each category, preferably genes that were found in more than one category, was measured in adrenal glands from IUGR and control male and female fetuses. As shown in Fig. 4 , the overexpression of Alb, Ambp, ApoE, Fga, Hp, Igfbp-1, and Trf is confirmed in IUGR fetuses. Although the increased expression is more evident in females than in males, there is no difference between the sexes (Student's t-test).
Effects of maternal low-sodium diet on fetal adrenal gland VEGF expression and apoptosis. To further confirm the results obtained by microarray analysis suggesting hypoxia, the expression of VEGF, used as a marker (44), was then measured in both sexes. VEGF mRNA expression was increased in adrenal glands from IUGR fetuses (P Ͻ 0.001, two-factor ANOVA; Fig. 5A ). An interaction between maternal treatment and sex was observed (P Ͻ 0.05, two-factor ANOVA) and the Student's t-test revealed a significant increase in females (P Ͻ 0.001). However, this small effect cannot be detected at the level of protein.
Microarray analysis suggested the presence of inflammation and oxidative stress in adrenal glands from IUGR female fetuses. These two processes are related to apoptosis that can be evaluated by a Bax/Bcl-2 ratio (30). It should be noted that for the experiments with Bax and Bcl-2, the design (separated immunoblots) did not allow comparison between sexes. Adrenal glands from IUGR female fetuses showed a decrease in Bax protein expression (P Ͻ 0.01, Student's t-test; Fig. 6A ). Bcl-2 protein expression was similar between adrenal glands from IUGR fetuses and their sex-matched controls (Fig. 6B) . The resulting Bax/Bcl-2 ratio was lower in adrenal glands from IUGR male (P Ͻ 0.05; Student's t-test) and female (P Ͻ 0.001; Student's t-test) fetuses, suggesting lower apoptosis (Fig. 6C) .
DISCUSSION
This study was conducted to investigate the possible alterations in the adrenal gland of IUGR fetuses induced by a maternal low-sodium diet. Results herein show that AT 1 R and P450aldo mRNA expression was enhanced, likely resulting in an increase in serum aldosterone levels. Concomitant to this, StAR mRNA levels and P45011␤ expression were reduced, leading to decreased circulating corticosterone concentrations. This was further highlighted by the differential expression of genes involved in lipid metabolism and steroidogenesis. In addition, mRNA levels of enzymes of the catecholaminergic pathway were overexpressed in adrenal glands of IUGR fetuses. This was associated with an increased expression of genes related to hypoxia, oxidative stress, and inflammation. Moreover, despite the increased expression of enzymes related to catecholamine synthesis in adrenal glands of IUGR fetuses, the epinephrine and norepinephrine adrenal levels were decreased in males and similar in females compared with sexmatched controls. Together, this could suggest an increase of catecholamine secretion. The overexpression of genes related to cell growth was accompanied by reduced apoptosis as indicated by the Bax/Bcl-2 ratio. Altered IUGR fetal adrenal gland steroidogenic pathway. The changes in aldosterone concentrations in the maternal circulation could partially account for the sevenfold increase in fetal serum aldosterone levels. However, the alterations in fetal adrenal steroidogenic enzymes suggest that the fetus, by itself, also contributes to this increase. The low serum sodium content in IUGR fetuses enhances the adrenal P450aldo mRNA levels probably via the higher AT 1 R expression. Indeed, previous reports showed that sodium restriction in adult male rats increases the AT 1 R levels in adrenal zona glomerulosa (20, 21).
RT-PCR and microarray results indicate that StAR mRNA levels were reduced in adrenal glands from day 22 IUGR fetuses. It has been shown that DAX1 (dosage-sensitive sex reversal, adrenal hypoplasia critical region, on chromosome X, gene 1), a nuclear receptor protein encoded by the Nr0b1 gene (nuclear receptor subfamily 0, group B, member 1), negatively regulates StAR gene expression (24) . In the microarray, Nr0b1 mRNA levels were upregulated in IUGR adrenal glands and thus, could be implicated in the decreased StAR expression. This decrease in StAR is concomitant with the decreased P45011␤ but not with the increased P450aldo. Such discrepancy between StAR and P450aldo/P45011␤ mRNA expression has already been demonstrated. A 9-day adenocorticotropic hormone treatment in rats induced increased StAR mRNA levels in adrenal zona glomerulosa and zona fasciculata but a decreased P450aldo and similar P45011␤ mRNA levels compared with adrenal glands from controls (22) . This discordance could also be explained by different regulation mechanisms between StAR and P450aldo gene expression. Indeed, it has been shown that cGMP-dependent protein kinase (PKG II) activated aldosterone release from zona glomerulosa cells but, in contrast to PKA, did not stimulate StAR gene expression (12). Values are expressed as fold changes in expression in IUGR female fetuses when compared with controls. Genes are considered to be differentially expressed when a minimum 2-fold (arbitrary cutoff) difference between control and experimental values is evident.
ApoE, a prominent component of triglyceride-rich lipoprotein particles mediating endocytotic uptake of lipoproteins by members of the low-density lipoprotein receptor family (1), was highly expressed in adrenal glands from IUGR fetuses (microarray and quantitative RT-PCR). ApoE mRNA is principally localized in zona fasciculata/reticularis cells of adult rat adrenal glands (29) where its expression is regulated in direct proportion to esterified cholesterol stores and is inversely proportional to the level of steroid production (33) . Thus, the decrease in serum corticosterone concentrations related to the reduced P45011␤ expression observed in IUGR fetuses is in agreement with enhanced ApoE expression.
The expression of acetyl-coenzyme A acetyltransferase 2 and 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) synthase 2 in fetal IUGR female rat adrenal glands was found to be increased. To our knowledge, this is the first study that reports the expression of these genes in fetal adrenal glands. In the liver, HMG-CoA synthase 2 is the rate-limiting step of the ketogenic pathway (16) . In gonads, it has been suggested to perform similar function to that of HMG-CoA synthase 1 in de novo cholesterol biosynthesis since its expression is localized in hormone-producing cells of rat testis and ovary. This indicates a link with hormone production rather than a role in the formation of ketone bodies in these organs (36) . While further investigations will be required to assess the role of HMG-CoA synthase 2 in this precise context, it may be related to steroidogenesis, such as that observed in gonads.
Increased IUGR fetal adrenal gland catecholaminergic pathway: causes and consequences. We found higher mRNA expression of TH, D␤H, and PNMT in adrenal glands from day 22 IUGR fetuses, suggesting that catecholamine synthesis is increased in these animals. However, the measurement of the catecholamine adrenal content reveals a reduction in the amount of norepinephrine and epinephrine in the adrenal glands of IUGR male fetuses and similar levels in females compared with glands from sex-matched controls. This could indicate that the catecholamines are secreted into the bloodstream of these fetuses. Indeed, it was shown that catecholamine content in the adrenal glands was decreased in IUGR rat fetuses but that the plasma levels were higher, suggesting a hypersecretion (17) . In adult rat, catecholamine secretion in adrenal medulla chromaffin cells is controlled by the cholinergic splanchnic nerve, whereas this innervation is absent at birth (39) , meaning that chromaffin cells have the capacity to release catecholamines without neural stimulation during fetal life (9) . It has been shown that stress, such as maternal hypoxia during the last 3 days of gestation, induces an increase in the levels of TH and D␤H mRNA in fetal adrenal glands 1 day prior to birth (18) . Adrenal hypoxia in the current IUGR model is supported by microarray analysis and quantitative RT-PCR, revealing the upregulation of many genes related to hypoxia, such as Igfbp1, aldolase A, and ceruloplasmin. VEGF expression was shown to be localized in adult mouse steroidogenic cells (42) , and hypoxia is a major trigger for its induction (44).
a Fig. 4 . Quantitative RT-PCR confirmation of the microarray in adrenal glands from day 22 IUGR male (white bars) and female (gray bars) fetuses. One gene from each category, preferably genes that were found in Ͼ 1 category, was assayed in triplicate using sets of primer designed by Qiagen. They were normalized using 18S as a housekeeping gene. Data are expressed as mean fold increases Ϯ SE vs. control fetuses of the same sex (sex-pooled adrenal glands from 5 or 6 litters/group). Alb, albumin; Ambp, ␣1 microglobulin/bikunin; ApoE, apolipoprotein E; Fga, fibrinogen-␣; Hp, haptoglobulin; Igfbp1, insulinlike growth factor binding protein 1; Trf, transferrin. Fig. 5 . VEGF expression in adrenal glands from day 22 control (white bars) and IUGR (gray bars) male and female fetuses. Sex-pooled adrenal glands from 6 and 10 litters/group, respectively, were used to evaluate expression of VEGF mRNA (A) and protein (B). Representative gels: each sample was performed in triplicate, 6 samples/group, and a negative control between IUGR and control samples. Fifty-well combs were used. For purposes of conciseness, 6 consecutive wells and representative of all the samples are illustrated herein, along with dividing lines for each 6-well series representing replicates for each sample. Results are expressed as means Ϯ SE. Two-factor ANOVA reveals a significant effect of maternal treatment for VEGF mRNA (P Ͻ 0.001) as well as an interaction between maternal treatment and sex for VEGF mRNA (P Ͻ 0.05). ***Mean values significantly different from control sex-matched animals (Student's t-test, P Ͻ 0.001).
In the present study, an increase in adrenal VEGF mRNA expression was found, and this underscores the presence of hypoxia. The absence of change in protein levels remains, however, to be elucidated. It was shown in PC12 cells, an adrenal chromaffin cell line, that ANG II through AT 2 R stimulates the expression of the hypoxia-inducible factor, a key mediator of hypoxic responses (48) . AT 2 R promotes catecholamine release in adrenal glands of adult rats (8) . In the study herein, adrenal glands from IUGR fetuses expressed higher levels of AT 2 R mRNA. Furthermore, in adult rat adrenal medulla, hypoxia induces catecholamine secretion via the generation of superoxide anions (19) . Stimulation of AT 1 R increases the generation of reactive oxygen species through the activation of NAD(P)H oxidase (47) . Microarray analysis pointed out differential expression of genes related to oxidative stress, e.g., decrease of superoxide dismutase 2. Together, the increase in ATRs, as well as the presence of hypoxia and oxidative stress, may explain higher levels of catecholamine synthesis and secretion in adrenal glands of IUGR fetuses. Interestingly, this elevation in catecholamines could contribute to the increased aldosterone production since catecholamines enhance its secretion in a paracrine manner through the ␤-adrenoceptors (25) .
Adrenal catecholamines have been demonstrated to be essential for the induction of many acute-phase proteins, a class of proteins whose plasma concentrations increase/decrease in response to inflammation (45) . Differential expression of Ͼ 20 genes implicated in immunological processes was observed in adrenal glands from IUGR fetuses. In fact, many of these genes code for acute-phase proteins (11) . Therefore, in IUGR fetuses, the observed increase in catecholamine synthesis as suggested by higher mRNA levels of TH, D␤H, and PNMT could stimulate the expression of these proteins, which in turn are involved in inflammation and immune response. Compared with adrenal glands from sex-matched controls, the reduced catecholamine levels in males, and the similar levels in females, suggested higher secretion of catecholamines in IUGR fetuses, which could be a response to the intrauterine insult.
All of these processes (inflammation, hypoxia, and oxidative stress) could presumably induce greater apoptosis. In the rat fetal adrenal gland, apoptosis has been shown to occur in the innermost portion of the cortex at the end of gestation (28) . It was quite surprising to observe a decrease of the Bax/Bcl-2 ratio in adrenal glands of IUGR fetuses, especially since microarray analysis revealed an overexpression of gene implicated in the regulation of cell growth. Fig. 6 . Fetal adrenal levels of the proapoptotic protein Bax (A), the antiapoptotic protein Bcl-2 (B), and the apoptotic index (C) in day 22 control (white bars) and IUGR (gray bars) male and female fetuses. Representative immunoblots and data from densitometric analyses expressed in arbitrary units relative to ␤-actin are shown for Bax (A) and Bcl-2 (B). Rat thymus lysate served as positive control and is represented separately on the left of each immunoblot. The Bax/Bcl-2 ratio (C) is represented using arbitrary units from densitometric analyses. Data for all densitometric analyses depicted represent means Ϯ SE from sex-pooled adrenal glands from 6 litters/group. These experiments were not designed to allow statistical analysis on the influence of sex (separated immunoblots). *P Ͻ 0.05, **P Ͻ 0.01, and ***P Ͻ 0.001, mean values significantly different from control sex-matched animals (Student's t-test).
Thus, a possible explanation might be that the higher activity of the zona glomerulosa (aldosterone production) and the medulla (catecholamine production) observed in the adrenal gland of IUGR fetuses favors cell growth instead of apoptosis. Indeed, in adrenal glands of male adult rats, a lowsodium diet promotes proliferation of steroidogenic cells in zona glomerulosa (26) . However, this should be investigated.
Perspectives and Significance
Alterations in adrenal steroidogenesis and catecholamine synthesis were observed in IUGR rat fetuses induced by a maternal low-sodium diet. These alterations were associated with the presence of hypoxia and oxidative stress and with the induction of genes involved in an inflammation-related acutephase response. Altogether, these findings suggest that the fetal environment induces major modifications in the adrenal gland that could have long-lasting health effects and may ultimately be implicated in the pathogenesis of high blood pressure (5) and cardiac hypertrophy (4) observed in IUGR adult animals of this model. The results obtained herein lead to future experiments to be conducted to understand, at a mechanistic level, how these fetal adrenal alterations affect the function of the kidney and heart and lead to the phenotype observed in 12-wk-old IUGR rats.
